Selenium Sulfide 2.25% Shampoo, 180mL bottle, Rx Only, Manufactured for: Bi-Coastal Pharma Int. LLC, Shrewsbury, NJ 07702, NDC 42582-900-06.
Published December 27, 2023 · Recall initiated: December 13, 2023
Summary
FDA records drug Class II recall D-0152-2024, published December 27, 2023 and initiated December 13, 2023. Recalling firm: Private Label Partners, Inc.; Status: Ongoing; Reported quantity: 3,396 bottles; Lot: Lot #220551, Exp: 2/28/2025. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
CGMP Deviations: Stability data does not support expiry date.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Private Label Partners, Inc.
- Distributor
- NJ
- Lot
- Lot #220551, Exp: 2/28/2025
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDATING 2% Miconazole Nitrate Athlete's Foot Spray Antifungal Spray Powder, NET WT 4.5 oz (128 g) cans,December 27, 2023
- FDAPhenytoin Oral Suspension, USP, 100 mg/4 mL, packaged in packaged in 4 mL unit dose cups (NDC 0904-7079-24),December 27, 2023
- FDANYSTATIN 5BU, Activity (as is): 6482 Units/mg, bulk powder container, Rx Only, For Prescription Compounding,December 27, 2023
- FDANYSTATIN 500 MU, Activity (as is): 6482 Units/mg, bulk powder container, Rx Only, For PrescriptionDecember 27, 2023
- FDAThe System is designed as a modular system with components that include an Overhead Tube Suspension withDecember 20, 2023
- FDAChange Healthcare Stratus Imaging PACS 1.4 and Stratus Imaging Share 1.4, a component of Stratus Imaging PACS.December 20, 2023
Questions about this recall
Was Selenium Sulfide 2.25% Shampoo, 180mL bottle, Rx Only, Manufactured for: Bi-Coastal Pharma Int. LLC, Shrewsbury, NJ 07702, NDC 42582-900-06. recalled?
Yes. FDA published recall D-0152-2024 on December 27, 2023. Reported hazard: CGMP Deviations: Stability data does not support expiry date.
What should I do if I have this product?
Voluntary: Firm initiated · Letter